These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study. Meyer ML; Sotres-Alvarez D; Steiner AZ; Cousins L; Talavera GA; Cai J; Daviglus ML; Loehr LR J Clin Endocrinol Metab; 2020 Mar; 105(3):e447-56. PubMed ID: 31917455 [TBL] [Abstract][Full Text] [Related]
24. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. Coviello AD; Legro RS; Dunaif A J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280 [TBL] [Abstract][Full Text] [Related]
25. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States. Dwivedi AK; Vishwakarma D; Dubey P; Reddy S Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Liang P; Xi L; Shi J; Li W; Zhao S; Deng Y; Wang R; Sun Y; Gu B; Yuan L; Zhang Y; Gu W; Wang W; Hong J Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496 [TBL] [Abstract][Full Text] [Related]
27. Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis. Greenwood EA; Yaffe K; Wellons MF; Cedars MI; Huddleston HG J Clin Endocrinol Metab; 2019 Jul; 104(7):2809-2819. PubMed ID: 30985868 [TBL] [Abstract][Full Text] [Related]
28. Factors associated with self-report of polycystic ovary syndrome in the Coronary Artery Risk Development in Young Adults study (CARDIA). Kim C; Schreiner PJ; Siscovick D; Wang A; Wellons MF; Ebong I; Vu TH; Appiah D; Catov J; Schisterman EF; Yin Z; Lewis CE BMC Womens Health; 2023 May; 23(1):248. PubMed ID: 37161406 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482 [TBL] [Abstract][Full Text] [Related]
30. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504 [TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Yilmaz B; Vellanki P; Ata B; Yildiz BO Fertil Steril; 2018 Feb; 109(2):356-364.e32. PubMed ID: 29331234 [TBL] [Abstract][Full Text] [Related]
32. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Taylor MC; Reema Kar A; Kunselman AR; Stetter CM; Dunaif A; Legro RS Hum Reprod; 2011 Aug; 26(8):2226-31. PubMed ID: 21505042 [TBL] [Abstract][Full Text] [Related]
33. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome. Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143 [TBL] [Abstract][Full Text] [Related]
35. A novel biochemical marker - Yetkin Yildirim G; Tola EN; Dağ I Gynecol Endocrinol; 2020 Aug; 36(8):673-677. PubMed ID: 31996062 [No Abstract] [Full Text] [Related]
36. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis. Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria. Weerakiet S; Bunnag P; Phakdeekitcharoen B; Wansumrith S; Chanprasertyothin S; Jultanmas R; Thakkinstian A Gynecol Endocrinol; 2007 Mar; 23(3):153-60. PubMed ID: 17454169 [TBL] [Abstract][Full Text] [Related]
39. The prevalence and features of the polycystic ovary syndrome in an unselected population. Azziz R; Woods KS; Reyna R; Key TJ; Knochenhauer ES; Yildiz BO J Clin Endocrinol Metab; 2004 Jun; 89(6):2745-9. PubMed ID: 15181052 [TBL] [Abstract][Full Text] [Related]
40. Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome. Kim JJ; Hwang KR; Choi YM; Moon SY; Chae SJ; Park CW; Kim HO; Choi DS; Kwon HC; Kang BM; Lee BS; Cho SH; Kim TJ; Kim T; Kim MJ; Park HY Fertil Steril; 2014 May; 101(5):1424-30. PubMed ID: 24613538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]